These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1377103)

  • 1. Reduction of endotoxin-induced vascular permeability by monoclonal antibodies against lipopolysaccharide determinants.
    Rubin RM; Noland J; Rosenbaum JT
    Circ Shock; 1992 Mar; 36(3):217-23. PubMed ID: 1377103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiendotoxin therapies for septic shock.
    Corriveau CC; Danner RL
    Infect Agents Dis; 1993 Feb; 2(1):44-52. PubMed ID: 8162353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Calandra T; Baumgartner JD; Glauser MP
    Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of type-specific and cross-reactive murine monoclonal antibodies directed against endotoxin during experimental sepsis.
    Dunn DL; Bogard WC; Cerra FB
    Surgery; 1985 Aug; 98(2):283-90. PubMed ID: 3895540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human monoclonal antibody HA-1A binds to endotoxin via an epitope in the lipid A domain of lipopolysaccharide.
    Bogard WC; Siegel SA; Leone AO; Damiano E; Shealy DJ; Ely TM; Frederick B; Mascelli MA; Siegel RC; Machielse B
    J Immunol; 1993 May; 150(10):4438-49. PubMed ID: 7683319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
    Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
    Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endotoxin-binding and -neutralizing properties of recombinant bactericidal/permeability-increasing protein and monoclonal antibodies HA-1A and E5.
    Marra MN; Thornton MB; Snable JL; Wilde CG; Scott RW
    Crit Care Med; 1994 Apr; 22(4):559-65. PubMed ID: 8143464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced survival in Pseudomonas aeruginosa septicemia associated with high levels of circulating antibody to Escherichia coli endotoxin core.
    Pollack M; Huang AI; Prescott RK; Young LS; Hunter KW; Cruess DF; Tsai CM
    J Clin Invest; 1983 Dec; 72(6):1874-81. PubMed ID: 6358257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralizing and cross-reactive antibodies against enterobacterial lipopolysaccharide.
    Müller-Loennies S; Brade L; Brade H
    Int J Med Microbiol; 2007 Sep; 297(5):321-40. PubMed ID: 17544324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of a monoclonal antibody against lipid A in endotoxic shock.
    Mead PS; Guo JP; Lefer AM; Pierce S; Palladino M
    Methods Find Exp Clin Pharmacol; 1994; 16(6):405-12. PubMed ID: 7837831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of methylprednisolone upon vascular permeability changes in endotoxic shock.
    Hubbard JD; Janssen HF
    Circ Shock; 1986; 18(3):179-92. PubMed ID: 3516437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the immune response to lipopolysaccharide. Existence of an interspecies cross-reactive idiotype associated with anti-lipid A antibodies.
    Su SD; Ward MM; Apicella MA; Ward RE
    J Immunol; 1990 Nov; 145(9):2994-3001. PubMed ID: 2212671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A synthetic peptide derived from bactericidal/permeability-increasing protein neutralizes endotoxin in vitro and in vivo.
    Jiang Z; Hong Z; Guo W; Xiaoyun G; Gengfa L; Yongning L; Guangxia X
    Int Immunopharmacol; 2004 Apr; 4(4):527-37. PubMed ID: 15099530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding characteristics and cross-reactivity of three different antilipid A monoclonal antibodies.
    Erich T; Schellekens J; Bouter A; Van Kranen J; Brouwer E; Verhoef J
    J Immunol; 1989 Dec; 143(12):4053-60. PubMed ID: 2687375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipopolysaccharide-binding and neutralizing activities of surfactin C in experimental models of septic shock.
    Hwang YH; Park BK; Lim JH; Kim MS; Park SC; Hwang MH; Yun HI
    Eur J Pharmacol; 2007 Feb; 556(1-3):166-71. PubMed ID: 17126323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of antilipopolysaccharide and anti-tumor necrosis factor monoclonal antibodies in a neutropenic rat model of Pseudomonas sepsis.
    Opal SM; Cross AS; Sadoff JC; Collins HH; Kelly NM; Victor GH; Palardy JE; Bodmer MW
    J Clin Invest; 1991 Sep; 88(3):885-90. PubMed ID: 1885775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated protein C increases sensitivity to vasoconstriction in rabbit Escherichia coli endotoxin-induced shock.
    Wiel E; Costecalde ME; Lebuffe G; Corseaux D; Jude B; Bordet R; Tavernier B; Vallet B
    Crit Care; 2006; 10(2):R47. PubMed ID: 16542507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymyxin B: an ode to an old antidote for endotoxic shock.
    Bhor VM; Thomas CJ; Surolia N; Surolia A
    Mol Biosyst; 2005 Sep; 1(3):213-22. PubMed ID: 16880985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diverse effects of triamicinolone on the ocular response to circulating endotoxin.
    Howes EL; McKay DG
    J Pathol; 1977 Mar; 121(3):149-58. PubMed ID: 328838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endotoxin as a therapeutic target in septic shock.
    Corriveau CC; Danner RL
    Infect Agents Dis; 1993 Feb; 2(1):35-43. PubMed ID: 8162352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.